Who Is Allowed to Prescribe GLP-1 Medications Online? (2026 Guide)

By WPG Research Team · Published · Last verified:

This page is regulatory information about online prescribing — not medical advice, not legal advice, and not a substitute for care from a clinician who can evaluate your specific situation.

Who can prescribe GLP-1 medications online — licensed clinician types and legitimacy rules 2026

Short answer: A licensed clinician with prescribing authority — most often a medical doctor (MD), doctor of osteopathic medicine (DO), nurse practitioner (NP/APRN), or physician assistant (PA) — when they hold an active license in the state where you, the patient, are physically located during the visit. That's the rule per U.S. HHS telehealth licensure guidance. The platform, brand, app, or clinic doesn't prescribe — a human clinician does. GLP-1 medications are not federal controlled substances, so the federal in-person requirement for controlled substances doesn't apply. Everything else in this guide is the detail behind that short answer.

Quick Answer: Who Can and Cannot Prescribe a GLP-1 Online

Person, role, or serviceCan they prescribe?Key qualifier
Physician (MD or DO)YesMust be licensed in your state
Nurse practitioner (NP/APRN)Often yesSome states allow independent prescribing; others require a transition period, physician relationship, collaboration, or supervision
Physician assistant (PA)Often yesState relationship rules vary — most require a written practice agreement with a physician, but not all
PharmacistSometimesOnly under a state-authorized prescribing protocol, not by default
Registered dietitianNoCan support care, not prescribe
Health coach or wellness consultantNoNot a prescriber
Med spa or weight-loss clinic (as a business)No — the individual clinician inside it canVerify the actual prescriber, not the brand
Pharmacy (as a business)NoPharmacies fill prescriptions, not write them
Online "research peptide" sellerNo legitimate pathwayThe FDA has warned consumers directly about these
Chatbot, AI, or automated intake aloneNoA real clinician must review and sign the prescription

Who Is Allowed to Prescribe GLP-1 Medications Online: The Full Role-by-Role Answer

A GLP-1 prescription is only as legitimate as the person who wrote it. Four credential types carry GLP-1 prescribing authority across the United States. Pharmacists are an edge case under specific state protocols. Everyone else you might encounter in an online weight-loss flow — coaches, dietitians, support staff, AI intake bots — cannot legally write your prescription, no matter what the marketing implies.

Physicians (MD and DO)

Medical doctors (MD) and doctors of osteopathic medicine (DO) have the broadest prescribing authority of any clinician type, in every U.S. state and DC. Both complete four years of medical school plus residency. DOs receive extra training in osteopathic manipulative treatment — useful for some clinical situations, irrelevant to GLP-1 prescribing. Their license to prescribe a GLP-1 is identical to an MD's.

What this means in practice

If you see "MD" or "DO" on your prescription, that clinician can write GLP-1 prescriptions for FDA-approved brand-name products and, in narrow situations, for properly compounded preparations. The only question that matters: is their license active in your state?

Nurse Practitioners (NP / APRN)

Nurse practitioners — also called advanced practice registered nurses (APRNs) — are nurses with master's or doctoral training in a clinical specialty. They write a meaningful share of the country's GLP-1 prescriptions. According to IQVIA's 2025 analysis of pharmacy claims data, NPs and PAs combined accounted for roughly 41% of anti-obesity GLP-1 claims and 35% of antidiabetic GLP-1 claims.

Whether an NP can prescribe independently depends on your state. The AANP's State Practice Environment map classifies every U.S. jurisdiction into three categories:

Full practice authority — NPs prescribe GLP-1s independently

Alaska, Arizona, Colorado, Connecticut, Delaware, Hawaii, Idaho, Iowa, Kansas, Maine, Maryland, Massachusetts, Minnesota, Montana, Nebraska, Nevada, New Hampshire, New Mexico, New York (after 3,600 supervised hours), North Dakota, Oregon, Rhode Island, South Dakota, Utah, Vermont, Washington, Wyoming, and DC. Recent legislation has expanded authority in additional states — check AANP directly for the current map.

Reduced practice — collaborative agreement required

Illinois, Indiana, Kentucky, Louisiana, Mississippi, New Jersey, Ohio, Pennsylvania, West Virginia, Wisconsin, and others. A career-long written collaborative agreement with a physician is required.

Restricted practice — physician supervision required

California (during AB 890 transition), Florida (independent practice only after 3,000 supervised hours), Georgia, Michigan, Missouri, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia.

If a telehealth platform's prescriber is an NP, that's normal and legitimate — provided the license matches your state and any state-required collaboration is in place.

Physician Assistants (PA)

Physician assistants are licensed clinicians whose prescribing authority depends on state law and practice setting. In most states, a PA prescribes under a written practice agreement with a supervising physician who reviews charts on a defined cadence. In a small but growing group of states, the relationship is more collaborative, and a few have moved toward Optimal Team Practice rules that don't require a specific physician agreement once the PA meets training and experience thresholds. In practical terms, a PA on a legitimate online GLP-1 platform can write your prescription. Their license — not the platform — is what you'd verify.

Pharmacists — The Important Nuance

Where most online GLP-1 marketing gets misleading

A pharmacist is a medication expert. Their default role is to dispense prescriptions written by another clinician and counsel you on safe use. That's not the same as independent prescribing.

Some states authorize pharmacists to prescribe certain medications under a statewide protocol or collaborative practice agreement — typically categories like hormonal contraception, smoking cessation, or travel medications. GLP-1 medications are not universally authorized for independent pharmacist prescribing. If an online program implies a pharmacist is writing your GLP-1 prescription, ask for the specific state protocol.

Legitimate version

A pharmacist counsels you on safe self-injection, manages dose questions, or fills your prescription.

Questionable version

A pharmacist alone "approves" your GLP-1 with no physician, NP, or PA involved. Ask. Most legitimate programs will tell you exactly who signed.

The Other Roles People Confuse With Prescribers

What Makes an Online GLP-1 Prescription Valid: The Four-Pillar Legitimacy Test

A legitimate online GLP-1 prescription rests on four pillars. If any one of them is missing, the prescription fails at least one core legitimacy check.
1

The prescriber holds an active license in your state

Telehealth licensure follows the patient, not the provider, per HHS Telehealth.gov. A telehealth company headquartered in New York cannot legally prescribe to a patient in Texas unless one of its clinicians is licensed in Texas. Some physicians expand their reach through the Interstate Medical Licensure Compact. What this looks like on a legitimate platform: the prescriber's full name and credential appear on your visit notes, prescription label, or account dashboard. You can search that name on your state's medical board or board of nursing website and see an active license.

2

A real clinical evaluation happened — not just a form

The FSMB Model Policy is clear: telemedicine evaluations must meet the same standard of care as in-person care. That generally means a real review of your medical history, current medications, weight and BMI, contraindications, and clinical eligibility for the FDA-approved use. Most states consider an internet questionnaire alone inadequate to establish the patient-provider relationship needed for prescribing. Red flag wording: 'Guaranteed approval before review.' 'Auto-approval if you fit the criteria.' Real prescribing requires a real review.

3

A state-licensed pharmacy dispenses the medication

A prescription is meaningless if it goes to an unlicensed pharmacy. Legitimate online programs send your prescription to a pharmacy licensed in your state — including out-of-state pharmacies that hold a non-resident license. For compounded products, the dispensing facility must be a Section 503A pharmacy (state-licensed, fills patient-specific prescriptions) or a Section 503B outsourcing facility (FDA-registered, larger-scale production). The FDA maintains a BeSafeRx resource for verifying state-licensed pharmacies.

4

An FDA-approved product OR a properly-justified compounded preparation

Through April 2025 there was a wide-open compounding window because the FDA listed semaglutide and tirzepatide as in shortage. That window has closed. Most compounded semaglutide and tirzepatide is no longer legally produced as an essential copy of Wegovy, Ozempic, Mounjaro, or Zepbound. Narrow exceptions exist when a prescriber documents a clinical reason — a documented allergy to an inactive ingredient, or a non-standard dose unavailable in the FDA-approved product. Legitimate paths in 2026: FDA-approved Wegovy, Ozempic, Zepbound, Mounjaro, Saxenda, Rybelsus, or Foundayo from a state-licensed pharmacy. Or a clinically-justified compounded preparation with the justification documented in your chart.

Does My Online GLP-1 Prescriber Need to Be Licensed in My State?

Yes. Telehealth licensure follows the patient, period.

If you live in Texas and you're at home during the visit, the clinician needs Texas authority — even if the telehealth company is headquartered in California and uses Massachusetts-based doctors.

A few state-specific rules that actually change what you can get prescribed online:

Before paying, do two checks: (1) is the platform actually authorized to prescribe in your state, and (2) does the visit type they're using meet your state's standard of care? CCHP keeps a state-by-state online-prescribing database that's a useful second source.

What Major Online GLP-1 Programs Publicly Say About Who Prescribes

We pulled the public statements from ten of the largest U.S. telehealth GLP-1 programs. This is a stated-policy comparison, not an endorsement of any program.

All statements below were verified against the named programs' public pages on .

ProgramWhat the public page statesUseful detail to surface
Walgreens Virtual HealthcareA doctor or nurse practitioner conducts the visit; assessment includes BMI and medical historyNames clinician roles directly; cash-pay model with manufacturer savings programs
CVS MinuteClinicA board-certified provider performs the evaluation. GLP-1 prescribing may not be available in all states. Compounded GLP-1 and controlled-substance medications for weight loss are not prescribedStrong state-availability caveat; FDA-approved medications only
MDLIVEA licensed physician may prescribe GLP-1 medications at their discretion as part of a weight management plan; not available in certain statesUseful proof that "online" still has state and clinician-judgment limits
PlushCareBoard-certified primary care doctors review medical history and provide prescriptions at physician discretionIncludes insurance and prior-authorization support
TeladocGLP-1 weight-loss medications are available only to members in eligible programs and require clinical approval by a Teladoc clinicianEmployer-plan eligibility can limit access even when prescribing is otherwise allowed
Lemonaid HealthA Lemonaid Health-affiliated healthcare provider will review and conduct a consultation; the page also discloses that compounded products are not FDA-approved or FDA-verifiedClear contrast between clinician access and compounded-medication disclosure
WeightWatchers ClinicMembers meet with a board-certified clinician, and if medication is safe and appropriate, the clinician writes a prescription for FDA-approved medicationSeparates nutrition/behavior support from the prescribing clinician
GoodRx Care DirectUnlimited access to licensed healthcare professionals who can write a prescription for GLP-1 weight-loss medication if it's a good fitFDA-approved brand-name medications only
NovoCare Pharmacy (Novo Nordisk direct)A GLP-1 medicine requires a prescription. "Talk to your prescriber, or we can connect you with one"Manufacturer-direct cash-pay path for Wegovy and Ozempic
LillyDirect (Eli Lilly direct)Connects patients to a third-party telehealth network for evaluation and Zepbound/Mounjaro/Foundayo prescribingManufacturer-direct cash-pay path for Lilly's GLP-1s
Legitimate programs disclose the clinician role, the medication type, the state availability, and the evaluation process. If you're looking at a program that won't name the clinician credential, won't say what state you can use it in, or won't say whether the medication is FDA-approved or compounded — those gaps are real, and they're the reason to keep verifying before paying.

Are Compounded GLP-1 Medications Still Legal Online in 2026?

Here's what actually changed, dated for clarity, drawn from FDA's own announcements:

Feb 21, 2025
FDA declared the semaglutide injection shortage resolved. The legal basis that allowed compounding pharmacies to mass-produce semaglutide copies during the shortage went away.
Feb 18, 2025
End of FDA enforcement discretion for 503A pharmacies/physicians compounding tirzepatide.
Mar 19, 2025
End of enforcement discretion for 503B outsourcing facilities compounding tirzepatide. Each carried a "or court decision if later" qualifier tied to Outsourcing Facilities Association v. FDA litigation.
Apr 22, 2025
End of enforcement discretion for 503A pharmacies/physicians compounding semaglutide.
May 22, 2025
End of enforcement discretion for 503B outsourcing facilities compounding semaglutide.
Dec 22, 2025
Novo Nordisk announced FDA approval of the oral Wegovy pill (high-dose semaglutide tablet) for chronic weight management — the first oral GLP-1 approved specifically for weight loss.
Mar 3, 2026
FDA announced 30 warning letters to telehealth companies for false or misleading claims about compounded GLP-1 products. FDA also stated it had sent thousands of broader misleading-ad letters to pharmaceutical and telehealth firms across the prior six months.
Apr 1, 2026
FDA approved Foundayo (orforglipron), a daily oral GLP-1 receptor agonist, for adults with obesity or overweight with at least one weight-related condition.
Apr 30, 2026
FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list; public comment period open through June 29, 2026.
Jul 1, 2026
CMS launches the Medicare GLP-1 Bridge demonstration. Eligible Part D beneficiaries may access certain GLP-1 medications for $50/month through December 31, 2027. Eligibility, prior authorization, and covered formulations still apply.

What this means for prescribing

The who can prescribe answer didn't change. The what they can legally prescribe did. Compounded semaglutide and tirzepatide are still available through some platforms — but the legal basis is narrower, the lawsuits are real, and the FDA has been explicit that mass compounding of essential copies is no longer permitted.

⚠️ FDA dosing-error alerts

The FDA has reported adverse events including hospitalizations associated with dosing errors involving compounded injectable semaglutide products, citing patient confusion around vial sizes, syringe selection, unit conversions, and varying concentrations. If your prescription is for a compounded product, ask: what concentration is dispensed, what is the dose in milligrams (and milliliters), and what training does the program provide for self-injection?

Per Novo Nordisk's July 2025 announcement, the company had filed 132 complaints against compounders across 40 states and obtained 44 permanent injunctions. That's the manufacturer's stated count, not a neutral court dataset — but it gives you a sense of the enforcement temperature.

How to Verify Your Online GLP-1 Prescriber in Under 5 Minutes

If you're already mid-intake on a platform and the screen is telling you your "provider will review your case" with no name, here's the workflow.

1

Get the prescriber's full name and credential

Where to find it: the platform's account dashboard, your visit notes, your prescription PDF, the email confirming your prescription was sent to the pharmacy, or by asking customer support directly. Every legitimate platform names the clinician. If yours won't, that's an answer too.

Credentials look like: "Jane Doe, MD," "John Smith, DO," "Maria Lopez, FNP-BC," "James Chen, PA-C." MD and DO are physicians. FNP, AGNP, ANP, PMHNP and similar -NP credentials are nurse practitioners. PA-C is a certified physician assistant.

2

Open your state's correct licensing board

The right database depends on the credential:

  • Physician (MD/DO): your state's medical board or Board of Medical Examiners
  • Physician assistant (PA): also the state medical board in most states (some states have a separate PA board)
  • Nurse practitioner (NP/APRN): your state's board of nursing, or Nursys for compact-state RN verification
StateMD/DO/PA lookupNP lookup
CaliforniaMedical Board of California (mbc.ca.gov)California Board of Registered Nursing
TexasTexas Medical Board (tmb.state.tx.us)Texas Board of Nursing
FloridaFL Dept of Health MQA Search (mqa-internet.doh.state.fl.us)Same MQA portal
New YorkNYS Education Dept Office of the ProfessionsSame portal
ArizonaArizona Medical Board (azmd.gov)Arizona Board of Nursing
North CarolinaNC Medical Board (ncmedboard.org)NC Board of Nursing
AlabamaAlabama Board of Medical Examiners (albme.gov)Alabama Board of Nursing

For states not listed here, search "[your state] medical board license lookup." Every U.S. state and DC offers a free public license-verification tool. A nationwide free tool — DocInfo.org, run by the FSMB — aggregates physician disciplinary data across all 50 states.

3

Search and read the result

Type the last name and first initial. The result page should show: license number, license status (active, inactive, expired, suspended, revoked), license issue date and expiration, medical school or nursing program, and any board actions or disciplinary documents. "Active" and "no disciplinary documents" is what you want to see. "Probation," "suspended," "limited," or "revoked" are reasons to ask the platform a hard question. Note: specialty information in some states is self-reported by the licensee and not verified by the board. License status, license number, and disciplinary actions are primary-source verified in every state's lookup.

4

Confirm the license is in your state

This is the one most people skip. A physician licensed in Massachusetts is not authorized to prescribe to you in Texas just because the platform's website is accessible from anywhere. Your prescriber needs to appear in your state's board database, or be authorized through an interstate compact your state participates in. If the name doesn't appear: try last name first initial, try alternate spellings, check whether the clinician practices under a different legal name, and — for NPs — check both the state board of nursing and Nursys. A clean license check confirms one of the four pillars. You still need to verify the visit process, medication source, pharmacy, dosing instructions, and follow-up.

What Red Flags Mean an Online GLP-1 Offer Probably Isn't Legitimate

Six patterns reliably indicate something is off. If any of these are present, slow down and verify before paying.

No named prescriber

Marketing says "our doctors" but you never see a name or credential. Real prescribers sign real prescriptions and put their names on charts.

"Guaranteed approval" or "approval before review"

Real prescribing requires a real clinical evaluation. A platform that promises approval before a clinician sees your intake either misstates its process or isn't following standard-of-care practice. Either is a problem.

No medical evaluation, no medical history

A 30-second yes/no form alone does not meet most states' standards for telehealth prescribing. Legitimate telehealth visits involve a consultation and a medical review of your history and symptoms.

"Research peptides," "for research use only," or "not for human consumption"

The FDA has specifically warned consumers about companies selling unapproved GLP-1 products direct-to-consumer under "research" labels while providing dosing instructions for human use. This is the most common counterfeit pathway. Do not use.

Overseas shipping with no U.S. prescription pathway

A pharmacy in another country shipping to your home, with no U.S.-licensed prescriber on file, is not a legitimate pathway. The drug may not be what the label says it is.

"Generic Wegovy," "generic Zepbound," or "the same as Ozempic"

There are no FDA-approved generic semaglutide or tirzepatide injection products as of May 2026. (Saxenda is the narrow exception.) The "same active ingredient" marketing line was used by some compounders and has been the subject of FDA warning letters and pharmaceutical company lawsuits.

Find a Legitimate GLP-1 Provider

Which Prescriber Is the Right Fit for Your Situation?

The cheapest, fastest, or most aggressive marketer is almost never the right answer. The right prescriber is the one who can actually treat your situation safely and stay involved while your dose adjusts.

Your situationA reasonable starting pointWhy
You have a primary care doctor you trustTalk to them firstContinuity, lab access, full medication history, and no extra subscription fee
You have type 2 diabetesYour PCP or an endocrinologistDiabetes medication interactions and glucose monitoring matter
Your PCP won't prescribe and you want a brand-name GLP-1A telehealth program that prescribes FDA-approved medications with insurance supportManufacturer savings programs and prior-authorization help can lower cost
You're on MedicareAsk your prescriber or Part D plan about the Medicare GLP-1 Bridge starting July 1, 2026CMS says eligible Part D beneficiaries may access certain GLP-1 medications for $50/month through the demonstration — access still depends on eligibility, prior authorization, and covered formulation
You're paying cash and want the lowest legitimate price for a brand-name GLP-1NovoCare Pharmacy direct (Wegovy/Ozempic) or LillyDirect (Zepbound/Foundayo/Mounjaro)Manufacturer-direct cash pricing
You found a med spa offerVerify the individual prescriber's license firstThe spa's brand doesn't prove anything about the clinician
You're considering a compounded GLP-1Ask the compounding-specific questions in the verification sectionLegal exposure and dosing safety have both changed in 2026
You have a complex medical history (pancreatitis, MEN2, prior thyroid cancer, pregnancy considerations)A clinician with close follow-up — endocrinologist, obesity medicine specialist, or your existing PCPThese are the conditions where contraindications matter most
The faster a platform approves you with zero questions, the less likely the prescriber is actually managing your care. Speed is not the metric.
Check Your Insurance Coverage with Ro

Questions to Ask Before Your First Online GLP-1 Visit

If you're going to spend money with a platform, get these answers first. Any legitimate program will answer them without hesitation.

About the prescriber

About the medication

About the clinical process

About cost

If a platform refuses or dodges any of these, that's data. Move on.

What We Actually Verified for This Page

High-change facts in this guide are dated where they appear. We update this page on a quarterly cadence.

U.S. Department of Health and Human Services, Telehealth.HHS.gov — licensure and cross-state practice guidance
Federation of State Medical Boards — Model Policy for the Appropriate Use of Telemedicine Technologies
American Association of Nurse Practitioners — State Practice Environment map (May 2026)
National Council of State Boards of Nursing (NCSBN) — APRN Compact status
National Conference of State Legislatures (NCSL) — NP Practice and Prescriptive Authority; PA Practice and Prescriptive Authority; Pharmacist Scope of Practice
FDA — Compounding Statements on GLP-1 Products; FDA Alerts on Dosing Errors with Compounded Semaglutide; Concerns with Unapproved GLP-1 Drugs; BeSafeRx; March 3, 2026 announcement on 30 warning letters; April 30, 2026 503B bulks list proposal
Centers for Medicare & Medicaid Services — Medicare GLP-1 Bridge program documentation
Center for Connected Health Policy (CCHP) — State Telehealth Online Prescribing database
IQVIA — 2025 analysis of mid-level prescribers and GLP-1 claims
Mississippi State Board of Medical Licensure — published Determination and Order (2023)
Public policy pages of Walgreens, CVS MinuteClinic, MDLIVE, PlushCare, Teladoc, Lemonaid Health, WeightWatchers, GoodRx, NovoCare Pharmacy, and LillyDirect (verified May 13, 2026)
Novo Nordisk public statement (July 2025) on 132 federal lawsuits and 44 permanent injunctions related to compounded semaglutide

We don't provide medical or legal advice. Use this page to verify the person prescribing your medication, then make decisions with a licensed clinician. Last verified: .

Why this page exists

You searched "who is allowed to prescribe GLP-1 medications online" because something prompted you to verify — maybe a TikTok about scams, an FDA warning letter headline, a price that seemed too good, or a screen that said "your provider will review your case" with no provider named. The answer isn't complicated, but the marketing around online weight-loss care often obscures it. An MD, DO, NP, or PA licensed in your state — operating under a real clinical process, dispensing through a state-licensed pharmacy, prescribing an FDA-approved or properly-justified compounded medication — can write your prescription online, legally. Whether your specific care is safe depends on the evaluation, medication source, dosing instructions, and follow-up. That's your prescriber's job, and your job to verify.

Related guides

Frequently Asked Questions

A licensed clinician with prescribing authority who is licensed in your state — most often a physician (MD or DO), nurse practitioner (NP/APRN), or physician assistant (PA), depending on state scope-of-practice rules. Pharmacists are an edge case, sometimes authorized under specific state protocols but not by default. GLP-1 medications aren't federal controlled substances, so the federal in-person rules for controlled substances don't apply.

Yes. Any MD, DO, NP, or PA licensed in your state can prescribe a GLP-1 if they judge it clinically appropriate. Some PCPs decline because they don't feel set up for long-term obesity management. That's a clinical judgment, not a legal limit. If your PCP declines, an obesity medicine specialist, endocrinologist, or a legitimate telehealth program is the next reasonable step.

Yes. In every U.S. state, nurse practitioners can prescribe Wegovy, Ozempic, and other GLP-1 medications when licensed in the patient's state. Per the AANP State Practice Environment map, NPs prescribe independently in roughly 30 jurisdictions including DC. In other states, an NP needs a collaborative or supervisory agreement with a physician — but the prescription itself is still legally valid.

Yes. Physician assistants can prescribe GLP-1 medications online when licensed in the patient's state. Per NCSL, the specific supervision, collaboration, or practice-agreement rule varies by state.

Not usually. A pharmacist's default role is dispensing prescriptions written by another clinician. Some states authorize pharmacist prescribing under statewide protocols for specific categories — GLP-1 medications are not universally on that list. If an online program implies a pharmacist is independently prescribing your GLP-1, ask for the specific state authority.

No. The prescriber needs to be licensed in your state — or authorized through an interstate compact your state participates in. The Interstate Medical Licensure Compact speeds up multi-state licensure for physicians. Wherever the clinician sits physically, you, the patient, determine which state's rules apply.

Yes, in most cases. The FSMB Model Policy and most state medical board rules allow a prescriber-patient relationship to be established via telemedicine when the standard of care is met. A few states require synchronous video specifically. GLP-1s aren't scheduled controlled substances, so the federal in-person requirement for controlled substances doesn't apply.

Probably not legally, depending on your state. Per CCHP, most states consider an internet questionnaire alone inadequate to establish a valid prescriber-patient relationship. Mississippi has disciplined a physician for prescribing semaglutide via an instant-messaging-only platform.

No. Compounded GLP-1s are not FDA-approved finished drug products. Following the resolution of the semaglutide and tirzepatide shortages in 2025, large-scale compounding of essential copies of these drugs is no longer legally permitted in most circumstances. The FDA has documented dosing-error adverse events with compounded injectable semaglutide products.

No legitimate U.S. pathway sells prescription GLP-1 medication for human use without a valid prescription from an authorized clinician. The FDA has issued direct consumer warnings about companies selling unapproved GLP-1 products under "research" or "not for human consumption" labels. These aren't a shortcut — they're a counterfeit risk.

Be cautious. For U.S. patients, the prescriber must be legally authorized to treat patients in your state. Most overseas prescribers aren't. Medications shipped from overseas without a U.S. prescription pathway carry significant counterfeit risk and may be subject to customs seizure.

No FDA-approved generic of these branded products is available as of May 2026. The exception in the broader GLP-1 category is liraglutide (Saxenda) — Teva launched an FDA-approved generic liraglutide injection in August 2025. A claim of "generic Wegovy" or "generic Zepbound" is a red flag.

None for prescribing authority. MDs and DOs have equivalent prescribing authority in every U.S. state. Both complete medical school, residency, and licensure. DOs receive additional training in osteopathic manipulative treatment, but their license to prescribe GLP-1 medications is identical.

Ready to find a legitimate GLP-1 prescriber?

Ro prescribes FDA-approved GLP-1 medications — Foundayo, Zepbound, Wegovy, and Ozempic — with licensed clinicians, free insurance coverage checking, and prior-authorization support included.

Start with Ro — $39 First Month